Dissertationen geleitet (9) Dissertationen, die von den Mitgliedern der Gruppe geleitet wurden

2024

  1. Advances in precision and safety of crispr-based gene targeting for primary hyperoxaluria type 1

    Torella, Laura

    unter der Leitung von Gloria González Aseguinolaza y Nerea Zabaleta Lasarte

2022

  1. Development of new strategies for the modulation of the immune response against gene therapy vectors

    ROS GAÑÁN, IRENE

    unter der Leitung von Mirja Hommel y Gloria González Aseguinolaza

2021

  1. Elucidating the mechanisms involved in liver damage and hepatitis B virus inhibition by hepatitis delta virus infection

    Camps Ramón, Gracián

    unter der Leitung von Rafael Aldabe Arregui y Gloria González Aseguinolaza
  2. Elucidating the mechanisms involved in HDV-induced pathogenesis

    Maestro Galilea, Sheila

    unter der Leitung von Gloria González Aseguinolaza y Rafael Aldabe Arregui
  3. Characterization of a Wilson Disease mouse model and development of novel therapies

    Barberia Urteaga, Miren

    unter der Leitung von Oihana Murillo Sauca y Gloria González Aseguinolaza

2019

  1. Characterization of new strategies to overcome the barrier of neutralizing antibodies in the aav-based gene therapy

    Salas Gómez, David

    unter der Leitung von Gloria González Aseguinolaza
  2. Glucocerebrosidase gene therapy in animal models of Parkinson Disease

    Sucunza, Diego

    unter der Leitung von José Luis Lanciego Pérez y Gloria González Aseguinolaza

2018

  1. Development of advanced genetic therapies for primary hyperoxaluria tipe I

    Zabaleta Lasarte, Nerea

    unter der Leitung von Gloria González Aseguinolaza y Juan Roberto Rodríguez Madoz
  2. Characterization of a mouse model for the study of hepatitis delta virus infection

    Usai, Carla

    unter der Leitung von Gloria González Aseguinolaza y Rafael Aldabe Arregui